Isosibiricin inhibits microglial activation by targeting the dopamine D1/D2 receptor-dependent NLRP3/caspase-1 inflammasome pathwayYan-Hang Wang(Peking University), Ke‐Wu Zeng(Peking University)Acta Pharmacologica SinicaSeptember 10, 201910.1038/s41401-019-0296-7Cited by 31SaveCiteExport RISWatch citationsRelated PapersQuinolone alkaloids with antibacterial and cytotoxic activities from the fruits of Evodia rutaecarpa|Fitoterapia|2013|57Molecular glue neferine induces BAP31 homodimerisation to disrupt endoplasmic reticulum–mitochondria crosstalk for anti‐neuroinflammation in ischaemic stroke|British Journal of Pharmacology|2025|1